As of 2025-07-03, the EV/EBITDA ratio of MEI Pharma Inc (MEIP) is 0.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MEIP's latest enterprise value is -4.49 mil USD. MEIP's TTM EBITDA according to its financial statements is -21.71 mil USD. Dividing these 2 quantities gives us the above MEIP EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 10.8x - 13.3x | 12.8x |
| Forward P/E multiples | 19.7x - 28.4x | 20.6x |
| Fair Price | (32.01) - 69.63 | 6.34 |
| Upside | -1433.7% - 2801.2% | 164.4% |
| Date | EV/EBITDA |
| 2025-07-02 | 0.21 |
| 2025-07-01 | 0.22 |
| 2025-06-30 | 0.19 |
| 2025-06-27 | 0.08 |
| 2025-06-26 | 0.12 |
| 2025-06-25 | 0.19 |
| 2025-06-24 | 0.25 |
| 2025-06-23 | 0.27 |
| 2025-06-20 | 0.27 |
| 2025-06-18 | 0.25 |
| 2025-06-17 | 0.25 |
| 2025-06-16 | 0.26 |
| 2025-06-13 | 0.24 |
| 2025-06-12 | 0.25 |
| 2025-06-11 | 0.23 |
| 2025-06-10 | 0.24 |
| 2025-06-09 | 0.26 |
| 2025-06-06 | 0.27 |
| 2025-06-05 | 0.28 |
| 2025-06-04 | 0.27 |
| 2025-06-03 | 0.28 |
| 2025-06-02 | 0.26 |
| 2025-05-30 | 0.26 |
| 2025-05-29 | 0.27 |
| 2025-05-28 | 0.30 |
| 2025-05-27 | 0.28 |
| 2025-05-23 | 0.28 |
| 2025-05-22 | 0.27 |
| 2025-05-21 | 0.28 |
| 2025-05-20 | 0.28 |
| 2025-05-19 | 0.30 |
| 2025-05-16 | 0.30 |
| 2025-05-15 | 0.28 |
| 2025-05-14 | 0.26 |
| 2025-05-13 | 0.30 |
| 2025-05-12 | 0.30 |
| 2025-05-09 | 0.32 |
| 2025-05-08 | 0.30 |
| 2025-05-07 | 0.31 |
| 2025-05-06 | 0.29 |
| 2025-05-05 | 0.31 |
| 2025-05-02 | 0.32 |
| 2025-05-01 | 0.31 |
| 2025-04-30 | 0.32 |
| 2025-04-29 | 0.33 |
| 2025-04-28 | 0.33 |
| 2025-04-25 | 0.30 |
| 2025-04-24 | 0.28 |
| 2025-04-23 | 0.34 |
| 2025-04-22 | 0.34 |